Introduction {#sec1}
============

Cardiovascular disease was the most common underlying cause of death worldwide in 2013, accounting for nearly one-third of all deaths ([@bib1]). According to the most recent report from the American Heart Association, \>1 in 3 American adults have ≥1 type of cardiovascular disease and 34% of American adults have hypertension ([@bib1]). This same report emphasizes nutrition and diet quality as one of the health behaviors to focus on for improving cardiovascular health.

Higher intakes of potassium, calcium, and magnesium and lower intakes of sodium have been associated with a lower risk of hypertension and cardiovascular disease ([@bib2]). The ratio of sodium to potassium intake was more strongly and consistently associated with cardiovascular disease and all-cause mortality than either single nutrient in a prospective analysis of a representative sample of US adults from NHANES III ([@bib4]). Dietary patterns emphasizing fruits, vegetables, and dairy are rich in minerals, tend to be lower in sodium, and are known to reduce blood pressure (BP) ([@bib5]). However, to our knowledge, a rigorous evaluation of other minerals and mineral ratios and their respective roles in BP has not been conducted.

Previously, we reported sodium and potassium intakes and their ratio in US adults from the 2011--2012 NHANES ([@bib6]). Only ∼10% of US adults met the sodium:potassium intake ratio associated with a reduced risk of cardiovascular mortality (1.0) ([@bib4]). Most adults (90% ± 0.8%) consumed \>2300 mg Na/d, primarily from mixed dishes, protein foods, and grains, and \<3% had potassium intakes \>4700 mg/d, primarily from vegetables and dairy. Furthermore, a recent analysis of the 2009--2012 NHANES showed that a substantial portion of US adults consumed less than the Estimated Average Requirement for calcium (19.6% ± 1.3%) and magnesium (22.3% ± 1.6%) from food and supplements combined ([@bib7]). Thus, most Americans have mineral intakes that are not aligned with dietary guidelines. Given the relation between intakes of each of these minerals and cardiovascular disease, the combined effect of high sodium intake and inadequate intake of potassium, calcium, and magnesium is of particular concern.

Examining the effects of multiple mineral intakes and their ratios on the risk of cardiovascular disease is important for developing dietary guidelines beyond a simplistic focus on sodium reduction. Our aim was to examine the associations of sodium, potassium, calcium, and magnesium intakes from food and dietary supplements, as well as their intake ratios, with BP.

Methods {#sec2}
=======

The NHANES is a nationally representative, cross-sectional health examination survey that samples noninstitutionalized, civilian US residents using a complex, stratified, multistage probability cluster sampling design. The NHANES is planned and conducted by the US CDC, National Center for Health Statistics. Written informed consent for all participants was obtained ([@bib8]). The NHANES protocol was approved by the National Center for Health Statistics research ethics review board. Data were collected through an in-home interview and a visit to a mobile examination center.

This analysis was completed with the use of 2 data cycles from NHANES 2011--2012 and 2013--2014 because the National Center for Health Statistics recommends that analysts combine ≥4 y of data to improve the reliability and stability of statistical estimates ([@bib9]). The inclusion criteria for this analysis were men and women aged ≥20 y, who were not pregnant or lactating, and with complete and plausible data. We excluded participants with an estimated glomerular filtration rate \<30 mL/min because impaired kidney function is related to BP independently of diet. The final analytical sample size was 8777. Demographic data in NHANES are collected with a computer-assisted personal interview in the participants' home, including sex, age, and race/ethnicity. The self-identified race/ethnic groups are classified by NHANES as non-Hispanic white, non-Hispanic black, Hispanic and Mexican American, non-Hispanic Asian, and "other" (referred to hereafter as white, black, Hispanic, and Asian). Estimates of the "other" race category are not presented separately in this analysis per the National Center for Health Statistics analytical guidelines. Self-reported tobacco smoking was categorized as "yes" or "no" based on current usage obtained from questionnaire data.

Brachial systolic and diastolic BP (SBP and DBP, respectively) readings were measured by a trained and certified physician in the mobile examination center after the participant had rested quietly in a seated position for 5 min ([@bib10]). Three consecutive blood pressure readings were obtained. If a BP measurement was interrupted or incomplete, a fourth attempt may be made. Hypertension was classified as an SBP of \>130 mm Hg or a DBP of \>80 mm Hg ([@bib11]). Because the distributions of SBP and DBP were strongly skewed, all of the analyses were performed by using logs of these variables. Extreme values beyond the 1^st^ and 99^th^ percentiles were Winsorized (replaced by the 1^st^ and 99^th^ percentile, respectively). Measured height and weight, collected in the mobile examination center, were used to calculate BMI (in kg/m^2^), which was treated as a continuous variable.

Dietary data in NHANES are collected as part of the What We Eat in America survey ([@bib12]) through two 24-h dietary recalls using the USDA's Automated Multiple-Pass Method ([@bib13], [@bib14]). The dietary recall captures all foods, beverages, and dietary supplements consumed within the previous 24 h. We used only day-1 data because this was collected in the mobile examination center at the same time concurrent BP readings were recorded, and our primary aim was to assess recent mineral intakes relative to BP. The usual intake of the same population showed a similar prevalence of mineral intakes as in our previous study, which used 2 time points of intake ([@bib6]), giving us confidence in our use of a single time point for diet assessment. We prioritized a close temporal diet assessment to BP because steady state to a shift in sodium intake occurs rapidly within 2--4 d ([@bib15]). The second diet recall assessment in NHANES can occur 3--10 d after BP is measured. Comprehensive information on the use of all types of prescription and nonprescription dietary supplements was first collected during the household interview; detailed collection procedures have been described elsewhere ([@bib16]). Briefly, trained interviewers asked participants to provide supplement product containers if they were available; containers were seen for \>80% of the reported supplements. Information about product type, name, frequency and duration of use, and dosage was recorded for each supplement reported during the interview. During the 24-h recall, trained interviewers asked participants if they used the products reported in the home and collect detailed information on any new products added since the home interview.

The USDA Food and Nutrient Database for Dietary Studies was used to convert foods and beverages as reported into gram amounts and to determine their respective energy and nutrient contents ([@bib19]). The National Center for Health Statistics provided the average daily intake of nutrients from all dietary supplements as calculated for individuals by using the number of days supplement use was reported, the reported amount taken per day, and the serving size unit from the product label. Nutrient contents from foods, beverages, and dietary supplements were combined and estimated for sodium, potassium, magnesium, and calcium, as well as the mineral ratios of sodium:potassium, sodium:calcium, sodium:magnesium, and calcium:magnesium.

The targeted values for those ratios were based on DRIs outlined by the Food and Nutrition Board of the National Academies of Sciences, Engineering, and Medicine (i.e., 2300 mg Na/d, 4700 mg K/d, 1000 mg Ca/d for women aged 19--50 y and men aged 19--70 y, 310 mg Mg/d for women aged 19--30 y and 400 mg/d for men aged 19--30 y) ([@bib20]). The Automated Multiple-Pass Method methodology used for the 24-h dietary recall has been validated for sodium. Reporting accuracy, calculated as the ratio of reported sodium intake to that estimated from the urinary biomarker, was 0.93 (95% CI: 0.89, 0.97) for men and 0.90 (95% CI: 0.87, 0.94) for women, on average ([@bib22]). Recovery biomarkers do not exist to estimate the magnitude of misreporting for calcium and magnesium.

All statistical analyses were performed using Statistical Analysis Software (version 9.4; SAS Institute, Inc.) and Statistical Analysis Software-callable Sudan software (version 11.0; RTI International). NHANES sample weights were used to account for differential nonresponse or noncoverage to adjust for planned oversampling of some groups and to adjust the dietary data for uneven representation of days of the week. Because intakes of sodium, potassium, calcium, and magnesium were strongly skewed to the right, all of the analyses were performed using logs of these variables and their ratios.

Extreme outliers of mineral intake of dietary supplement users were Winsorized to reduce their influence. Regression models were used to examine the association of individual minerals and their ratios with SBP, DBP, and hypertension controlled for known covariates. Significance was set at *P* ≤ 0.05, except for the race comparison, which was set at *P* \< 0.005 to adjust for the 10 comparisons.

Parallel analyses were performed for SBP and DBP. A model for assessing BP was developed using the following explanatory variables: age, expressed as linear and quadratic terms; a binary indicator of BP medication usage; interactions of age variables with BP medication usage; race; BMI; and a binary indicator of current smoking. Effects of individual mineral intakes and their ratios were assessed by adding each of these terms to the basic model. Subsets of these mineral variables were also examined.

Results {#sec3}
=======

 {#sec3-1}

### Mineral intakes {#sec3-1-1}

Subject characteristics for the analytical sample of 4395 men and 4382 women meeting our eligibility criteria are given in [**Table 1**](#tbl1){ref-type="table"}. Usual intakes of sodium, potassium, calcium, and magnesium by sex and selected characteristics are shown in [**Table 2**](#tbl2){ref-type="table"}. Sodium intakes were \>2300 mg/d for most Americans. Usual intakes were below recommendations for potassium, calcium, and magnesium. Although intake represents the total intake from all foods, beverages, and supplements for all 4 minerals, dietary supplements do not contribute substantially to sodium or potassium intakes, so intake of these minerals will mainly come from foods and beverages. Mineral intake ratio distributions relative to calculated ratios from DRIs for individual minerals for men and women are shown in [**Figure 1**](#fig1){ref-type="fig"}. Less than 2% of Americans achieved recommended intake ratios for sodium:potassium, and \<16% consumed recommended intakes for sodium:calcium. Sex differences were observed with other mineral intake ratios. For women, ∼7% achieved recommended intake ratios compared with men, at 14%, for sodium:magnesium. For women, approximately one-third compared with more than half of men met recommended intakes for calcium:magnesium.

![Sodium:potassium (A, E), sodium:magnesium (B,F), sodium:calcium (C, G), and calcium:magnesium (D, H) intake ratios in US women (A-D) and men (E-H). Shaded areas indicate those achieving recommended intake ratios.](nxy199fig1){#fig1}

###### 

Participant characteristics in US adults by sex: NHANES 2011--2014^[1](#tb1fn1){ref-type="table-fn"}^

                                                                                                 Men          Women
  ---------------------------------------------------------------------------------------------- ------------ ------------
  Age, y                                                                                         45.9 ± 0.5   47.7 ± 0.5
  BMI, kg/m^2^                                                                                   28.7 ± 0.1   29.2 ± 0.2
  Race/ethnicity, %                                                                                           
   Non-Hispanic white                                                                            68           68
   Non-Hispanic black                                                                            10           11
   Hispanic                                                                                      15           14
   Non-Hispanic Asian                                                                            4            5
  Current smoker, %                                                                                           
   Yes                                                                                           21           17
   No                                                                                            79           83
  Taking blood pressure medication, %                                                                         
   Yes                                                                                           25           27
   No                                                                                            75           73
  Blood pressure, mm Hg                                                                                       
   Systolic                                                                                      123 ± 0.4    120 ± 0.4
   Diastolic                                                                                     72 ± 0.3     70 ± 0.3
  Hypertension (systolic blood pressure \>130 mm Hg or diastolic blood pressure \>80 mm Hg), %   35           29

^1^Values are means ± SEs unless otherwise stated.

###### 

Estimated intakes of sodium, potassium, calcium, and magnesium in US adults by sex: NHANES 2011--2014^[1](#tb2fn1){ref-type="table-fn"}^

                                                                              Intakes, mg/d                                                                                              
  ------------------------------------------------------------- ------ ------ ---------------- --------------- ------------ ------------ --------------- --------------- --------------- ------------
  Total sample, *n*                                             4395   4382   4194 ± 34        3018 ± 23       3105 ± 32    2371 ± 27    1186 ± 16       1070 ± 14       370 ± 4         296 ± 3
  Race/ethnicity, %                                                                                                                                                                      
   Non-Hispanic white                                           68     68     4189 ± 40        2967 ± 30       3116 ± 42    2403 ± 39    1234 ± 19       1135 ± 18       377 ± 6         303 ± 5
   Non-Hispanic black                                           10     11     4077 ± 85        3112 ± 58       2792 ± 48    2176 ± 36    981 ± 25        857 ± 19        329 ± 8         263 ± 4
   Hispanic                                                     15     14     4325 ± 78        3092 ± 54       3144 ± 48    2391 ± 41    1186 ± 29       1013 ± 17       373 ± 7         288 ± 5
   Non-Hispanic Asian                                           4      5      4212 ± 126       3366 ± 92       2949 ± 61    2361 ± 37    914 ± 27        875 ± 26        372 ± 9         301 ± 7
   Racial differences^[2](#tb2fn2){ref-type="table-fn"}^                      No differences   A \> W          H,W \> A,B   W,H,A \> B   W,H \> B,A      W \> H \> A,B   W,H,A \> B      W,A,H \> B
  Hypertension (130/80 mm Hg), %                                35     29     4058 ± 46        2928 ± 52       3030 ± 41    2337 ± 42    1126 ± 19       1104 ± 28       360 ± 6         263 ± 6
  No hypertension, %                                            65     71     4267 ± 37        3055 ± 27       3145 ± 33    2385 ± 25    1218 ± 18       1056 ± 16       375 ± 5         297 ± 3
   Hypertension difference^[3](#tb2fn3){ref-type="table-fn"}^                 No HTN \> HTN    No HTN \> HTN   nd           nd           No HTN \> HTN   nd              No HTN \> HTN   nd

^1^Values are means ± SEs and population percentages presented by sex of estimated usual intakes of sodium, potassium, calcium, and magnesium. A, Asian; B, black; H, Hispanic; HTN, hypertension; nd, no difference; W, white.

^2^There were 10 comparisons. The adjusted *P*-value requirement for each comparison is 0.005.

^c^Hypertension is defined as systolic blood pressure \>130 mm Hg or diastolic blood pressure \>80 mm Hg. "No HTN \> HTN" indicates that individuals who did not have hypertension had significantly higher intakes than individuals who did have hypertension.

The variability in mineral intakes and mineral intake ratios that was explained after adjusting for sex, age, BP medication, interaction of age and BP medication, race/ethnicity, BMI, and current smoking status ranged from 5% for calcium, sodium:calcium, and calcium:magnesium to 14% for sodium. Men had higher intakes of all minerals and higher intake ratios of sodium:potassium, sodium:magnesium, and sodium:calcium, but not of calcium:magnesium, compared with women (*P* \< 0.0001). Age was a significant factor (*P* \< 0.0001) of sodium, potassium, and magnesium intakes as well as the intake ratios of sodium:potassium, sodium:magnesium, and calcium:magnesium. Among both sexes, blacks consumed less sodium, potassium, and magnesium than other racial/ethnic groups. The sodium:potassium intake ratio was greater for blacks and Asians than Hispanics or whites. The order of calcium intake by race was white \> Hispanic \> Asian and black.

### BP {#sec3-1-2}

Many factors beyond diet were strongly associated with BP ([**Table 3**](#tbl3){ref-type="table"}). Age explained 26% of the variation in SBP for women and only 10% for men. The addition of BP medication and its interaction term with age, race/ethnicity, BMI, and smoking status explained an additional 5% for women (*R*^2 ^= 0.31) and men (*R*^2 ^= 0.16). For DBP, age explained 8% of the variation for women and 12% for men. The addition of BP medication and its interaction with age, race/ethnicity, BMI, and smoking status explained a total of 11% of the variation in women (*R*^2 ^= 0.11) compared with 14% in men (*R*^2 ^= 0.14). [**Figure 2**](#fig2){ref-type="fig"} shows how BP varies with age and BP medication usage. BP was higher for those who use BP medication and the difference decreases with age.

![Variations in SBP (A, C) and DBP (B, D) in US women (A, B) and men (C, D) with age, blood pressure medication usage, and their interaction. The solid lines indicate those taking blood pressure medication, and the dashed lines indicate those who are not taking blood pressure medication. DBP, diastolic blood pressure; SBP, systolic blood pressure.](nxy199fig2){#fig2}

###### 

Predictors of SBP in the US NHANES 2011--2014^[1](#tb3fn1){ref-type="table-fn"}^

                                                       log(SBP)   log(DBP)                                                            
  ---------------------------------------------------- ---------- ---------- ---------- ------------ ---------- ---------- ---------- ------------
  Women (*n* = 4382)                                                                                                                  
   Intercept                                           4.64                                          4.35                             
   Age, y                                              0.003      0.000223   \<0.0001                0.0026     0.000273   \<0.0001   
   Age-squared                                         0.00004    0.000012   0.0023                  −0.00011   0.000012   \<0.0001   
   BP medication                                                                                                                      
    No                                                 −0.11      0.029628   0.0010                  −0.25      0.042142   \<0.0001   
    Yes                                                0          0                                  0          0                     
   Age by BP medication                                −0.0016    0.000634   0.0154                  −0.0048    0.000907   \<0.0001   
   Age-square by BP medication                         0.000031   0.000019   0.1045                  0.000058   0.000022   0.0147     
   Race/ethnicity^[2](#tb3fn2){ref-type="table-fn"}^                         \<0.0001   B \> A,H,W                         \<0.0001   A,B,W \> H
    Asian                                              0.0083     0.007010                           0.0051     0.008509              
    Black                                              0.033      0.005772                           −0.0039    0.008644              
    Hispanic                                           −0.00015   0.005343                           −0.031     0.008321              
    Other                                              0.012      0.013597                           −0.029     0.018877              
    White                                              0          0                                  0          0                     
   BMI                                                 0.0027     0.000368   \<0.0001                0.0018     0.000318   \<0.0001   
   Smoker                                                                                                                             
    No                                                 −0.0074    0.004666   0.1218                  0.017      0.006426   0.0114     
    Yes                                                0          0                                  0          0                     
  Men (*n* = 4395)                                                                                                                    
   Intercept                                           4.72                                          4.20                             
   Age, y                                              0.0018     0.000193   \<0.0001                0.0032     0.000224   \<0.0001   
   Age-squared                                         0.000044   0.000009   \<0.0001                −0.00015   0.000011   \<0.0001   
   BP medication                                                                                                                      
     No                                                −0.10      0.033611   0.0048                  −0.13      0.060934   0.0347     
    Yes                                                0          0                                  0          0                     
   Age by BP medication                                −0.0019    0.000716   0.0112                  −0.0029    0.001254   0.0262     
   Age-squared by BP medication                        0.000012   0.000020   0.5424                  0.000027   0.000030   0.3852     
   Race/ethnicity^[2](#tb3fn2){ref-type="table-fn"}^                         \<0.0001   B \> A,H,W                         0.0001     A \> H,W
    Asian                                              0.015      0.005660                           0.027      0.007614              
    Black                                              0.042      0.005344                           0.0046     0.009244              
    Hispanic                                           0.0027     0.004171                           −0.022     0.009696              
    Other                                              0.025      0.012920                           −0.0062    0.017611              
    White                                              0          0                                  0          0                     
   BMI                                                 0.0035     0.000403   \<0.0001                0.0036     0.000462   \<0.0001   
   Smoker                                                                                                                             
    No                                                 −0.015     0.005271   0.0095                  0.012      0.006155   0.0693     
    Yes                                                0          0                                  0          0                     

^1^A, Asian; B, black; BP, blood pressure; DBP, diastolic blood pressure; H, Hispanic; SBP, systolic blood pressure; W, white.

^2^There were 10 comparisons. The adjusted *P*-value requirement for each comparison was 0.005.

When added to these models, intakes of minerals or their ratios entered individually explained \<1% of the variation for SBP. Final models for SBP resulted in *R*^2^ of 0.31 for women and 0.15 for men ([**Table 4**](#tbl4){ref-type="table"}). Significant positive relations were found for SBP with sodium:potassium (*P* \< 0.01) and sodium:magnesium (*P* \< 0.02) in women and with sodium:potassium (*P* \< 0.02), sodium:calcium (*P* = 0.001), and calcium alone (*P* = 0.001, inverse) in men. Models that included combinations of single minerals or their ratios slightly improved the amount of variability in SBP accounted for in women (*R*^2 ^= 0.31). For men, adding all single mineral intakes to the model resulted in a slightly better model of SBP (*R*^2 ^= 0.16) than by including minerals or mineral ratios one at a time in the model. Final models for DBP resulted in an *R*^2^ of 0.11 for women and 0.14 for men ([Table 4](#tbl4){ref-type="table"}). Models that included combinations of single minerals or their ratios made little difference in the model for DBP for women (*R*^2 ^= 0.11) and men (*R*^2 ^= 0.15).

###### 

Dietary-mineral predictors of SBP and DBP in the US NHANES 2011--2014^[1](#tb4fn1){ref-type="table-fn"}^

                                                  Women log(SBP)   Women log(DBP)   Men log(SBP)   Men log(DBP)                                                           
  ----------------------------------------------- ---------------- ---------------- -------------- -------------- ------ ------ --------- ------- ------ --------- ------ ------
  Model from [Table 3](#tbl3){ref-type="table"}                                     0.31                                 0.11                     0.15                    0.14
  Mineral intake (log)                                                                                                                                                    
   Sodium                                         0.0054           0.13             0.31           0.00052        0.92   0.11   0.00043   0.90    0.15   0.0075    0.29   0.14
   Potassium                                      −0.0063          0.14             0.31           −0.0048        0.33   0.11   −0.0063   0.08    0.15   0.0062    0.41   0.14
   Calcium                                        −0.00099         0.80             0.31           0.004          0.30   0.11   −0.0082   0.001   0.15   −0.0016   0.71   0.14
   Magnesium                                      −0.0061          0.16             0.31           −0.0051        0.27   0.11   −0.003    0.29    0.15   −0.002    0.80   0.14
  Mineral intake ratios (log)                                                                                                                                             
   Sodium:potassium                               0.014            0.01             0.31           0.006          0.30   0.11   0.011     0.01    0.15   0.0041    0.57   0.14
   Sodium:calcium                                 0.0045           0.28             0.31           0.00079        0.89   0.11   0.01      0.001   0.15   0.004     0.45   0.14
   Sodium:magnesium                               0.011            0.02             0.31           0.0063         0.27   0.11   0.0065    0.09    0.15   0.0081    0.30   0.14
   Calcium:magnesium                              0.0043           0.35             0.31           0.0046         0.36   0.11   −0.0064   0.08    0.15   0.0023    0.70   0.14

^1^Values were adjusted for age, age-squared, blood pressure medication, interactions of age and age-squared with blood pressure medication, race, BMI, and smoking. DBP, diastolic blood pressure; SBP, systolic blood pressure.

With the use of logistic regression models to predict the incidence of hypertension (SBP \>130 or DBP \>80 mm Hg), calcium intake was inversely associated with hypertension in men only after adjusting for age, BP medication, race/ethnicity, BMI, and smoking status (estimate of β = −0.1337, *P* = 0.03).

Discussion {#sec4}
==========

In this cohort of a nationally representative sample of US adults, we observed that age and race/ethnicity explained most of the variation in BP. The intake ratios of sodium:potassium, but not sodium and potassium added individually, contributed weakly but significantly to models for SBP but not DBP. If potassium is increased from the average intake of 2371 mg/d to the recommended intake of 4700 mg/d, and sodium intake is decreased from the average of 3018 mg/d to 1500 mg/d, SBP is predicted to decrease from the averages of 119 mm Hg to 117 mm Hg. In addition, calcium intake alone was inversely associated and the intake ratio of sodium:calcium was positively associated with SBP in men. Although the variation explained appears to be quite small, on the population level this may have meaningful implications. Even small reductions in BP have large health benefits ([@bib23]).

Meta-analyses of randomized controlled trials have consistently identified a positive relation between sodium reduction and BP ([@bib24], [@bib25]). The evidence for a relation between adequate potassium and BP reduction was considered moderate by the 2010 Dietary Guidelines for Americans Advisory Committee on the basis of 36 clinical trials and 17 cohort studies evaluated from the 2005 committee plus an additional 10 new studies ([@bib26]). In a Cochrane review of 13 randomized controlled trials, the relation between calcium supplementation and BP was considered weak due to poor quality of the evidence ([@bib27]).

Dietary pattern interventions, notably the Dietary Approaches to Stop Hypertension (DASH) trials, have considered that reduction in BP may be due to foods rich in potassium, calcium, and magnesium, with further reductions in BP with reduction in sodium intakes ([@bib5], [@bib28]). However, effects of intakes of these combined nutrients have been less rigorously studied. Considering multiple nutrients (i.e., potassium, calcium, and magnesium) is important for understanding the effect of diet quality on BP because they may modify the response to dietary sodium. High dietary sodium intakes can alter mineral excretion by increasing intravascular volume. An increase in urinary calcium was associated with increased SBP in 2 large cohorts: the International Study of Macro- and Micronutrients in Blood Pressure (INTERMAP) and the International Cooperative Study on Salt, Other Factors, and Blood Pressure ([@bib29]). An older Cochrane review of randomized controlled trials did evaluate the effect of mineral ratios on BP and reported no significant effects, but the randomized controlled trials were few and not of high quality ([@bib30]). In the Nurses' Health Study II, potassium supplementation, but not calcium or magnesium supplementation, was effective at lowering BP after 16 wk and combined supplements were not better than potassium alone ([@bib31]). Several epidemiologic studies have considered the combined effects of sodium and potassium intakes only on BP. Consistent with our findings, using urinary excretion rates as a biomarker for sodium intakes, a lower sodium to potassium intake ratio showed a stronger relation with lower BP than either nutrient alone ([@bib32], [@bib33]). More recently in Shandong and Jiangsu, China, in adults, increased sodium intakes, sodium-to-potassium intake ratio, and reduced potassium intakes were associated with higher BP ([@bib34]). Considering additional minerals or their ratios together had minor contributions for explaining the variance in BP by sodium:potassium alone in our study. In the INTERMAP Study in 17 populations, a recent evaluation of contributing nutrients to BP showed that 24-h sodium and sodium:potassium excretions in multiple-variant analysis significantly predicted BP, but 80 other dietary variables did not attenuate the relation ([@bib35]). Because mineral intakes tend to be highly correlated, their separate effects are not easily distinguished.

Strengths of this study include the use of a nationally representative cohort of adults. The sampling period of 2011--2014 from NHANES included a large sample of Asians for the first time. We examined 4 key minerals important to reducing the risk of high BP and their intake ratios, including from food and dietary supplements.

This study also has limitations. We chose to use a single 24-h dietary recall taken at the time of outcome measure assessment, which does not allow determination of individual variation. Self-reported sodium intake is much less reliable than 24-h urinary sodium and reporting accuracy is less for women than for men ([@bib22]). This cross-sectional analysis precludes effects that may occur over time. When compared with 24-h urinary sodium excretion, USDA\'s Automated Multiple-Pass Method is accurate for assessing sodium intake in normal-weight individuals but is less accurate in obese individuals. The Automated Multiple-Pass Method recall underestimated intake by \>20% in obese individuals ([@bib22]). The finding that few adults met the recommended intake ratios reduced the range of mineral intake ratios, potentially limiting the true strength of a relation between mineral intake ratios and BP. We cannot rule out the possibility of reverse causality for the contribution of BP medications in our models.

In summary, we found very small benefits of lower intake ratios of sodium:potassium, sodium:magnesium, and sodium:calcium for protection against hypertension. Considering intakes of multiple nutrients as a predictor of diet quality will likely inform risks of chronic disease more than single-nutrient evaluations. More controlled feeding studies are needed to better help us understand how minerals modulate BP.
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